Researchers compared IFN production of patients with systemic lupus erythematosus who received a monoclonal antibody with those who received placebo to determine any improvement in disease activity.
The American College of Rheumatology and National Psoriasis Foundation released a guideline of recommendations for active PsA among treatment‐naïve individuals.
Hepatitis C viremia and HIV viremia were the greatest predictors of acute kidney injury (AKI) during treatment with tenofovir disoproxil fumarate (TDF), according to the r
What challenges do you see with your asthma patients? This was the subject of Dr Lily Higgins’ session at the American Lung Association’s LUNGFORCE Expo 2019. See what challenges were discussed here.
After a clinical trial demonstrated its efficacy, the FDA approved a new treatment option for adult and pediatric patients with a rare, inherited metabolic disorder.
The US Food and Drug Administration recently approved the first pill with an embedded digital ingestion tracking system for patients with schizophrenia, bipolar disorder, and depression.
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved Simponi Aria for 2 new indications in adult patients.
